Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects

British Journal of Clinical Pharmacology

Volumn 72, Issue 6, 2011, Pages 985-989

  Chin, Paul K L ^a   Jensen, Berit P ^a   Larsen, Helle S ^a   Begg, Evan J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Ageing; Lorazepam; Oxazepam; Protein binding; Temazepam; Ultrafiltration

Indexed keywords

LORAZEPAM; OXAZEPAM; SERUM ALBUMIN; TEMAZEPAM;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; EX VIVO STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; LORAZEPAM; MALE; MIDDLE AGED; OXAZEPAM; PROTEIN BINDING; SERUM ALBUMIN; TEMAZEPAM; YOUNG ADULT;

EID: 80855124330     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.04036.x     Document Type: Article

References (21)

1. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57: 6-14.
2. Le Couteur DG, McLean AJ. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 1998; 34: 359-73.
3. Durnas C, Loi CM, Cusack BJ. Hepatic drug metabolism and aging. Clin Pharmacokinet 1990; 19: 359-89.
4. Butler JM, Begg EJ. Free drug metabolic clearance in elderly people. Clin Pharmacokinet 2008; 47: 297-321.
5. Kraus JW, Desmond PV, Marshall JP, Johnson RF, Schenker S, Wilkinson GR. Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther 1978; 24: 411-9.
6. Greenblatt DJ, Allen MD, Locniskar A, Harmatz JS, Shader RI. Lorazepam kinetics in the elderly. Clin Pharmacol Ther 1979; 26: 103-13.
7. Aaltonen L, Kanto J, Arola M, Iisalo E, Pakkanen A. Effect of age and cardiopulmonary bypass on the pharmacokinetics of lorazepam. Acta Pharmacol Toxicol (Copenh) 1982; 51: 126-31.
8. Shull HJ, Wilkinson GR, Johnson R, Schenker S. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med 1976; 84: 420-5.
9. Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. Oxazepam kinetics: effects of age and sex. J Pharmacol Exp Ther 1980; 215: 86-91.
10. Murray TG, Chiang ST, Koepke HH, Walker BR. Renal disease, age, and oxazepam kinetics. Clin Pharmacol Ther 1981; 30: 805-9.
11. Divoll M, Greenblatt DJ, Harmatz JS, Shader RI. Effect of age and gender on disposition of temazepam. J Pharm Sci 1981; 70: 1104-7.
12. Smith RB, Divoll M, Gillespie WR, Greenblatt DJ. Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam. J Clin Psychopharmacol 1983; 3: 172-6.
13. Johnson RF, Schenker S, Roberts RK, Desmond PV, Wilkinson GR. Plasma binding of benzodiazepines in humans. J Pharm Sci 1979; 68: 1320-2.
14. Divoll M, Greenblatt DJ. Effect of age and sex on lorazepam protein binding. J Pharm Pharmacol 1982; 34: 122-3.
15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
16. Larsen HS, Chin PK, Begg EJ, Jensen BP. Quantification of total and unbound concentrations of lorazepam, oxazepam and temazepam in human plasma by ultrafiltration and LC-MS/MS. Bioanalysis 2011; 3: 843-52.
17. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44: 1051-65.
18. Barre J, Chamouard JM, Houin G, Tillement JP. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid. Clin Chem 1985; 31: 60-4.
19. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med 2009; 47: 596-603.
20. Howard ML, Hill JJ, Galluppi GR, McLean MA. Plasma protein binding in drug discovery and development. Comb Chem High Throughput Screen 2010; 13: 170-87.
21. Hinderling PH, Hartmann D. The pH dependency of the binding of drugs to plasma proteins in man. Ther Drug Monit 2005; 27: 71-85.